| 9.09.10 |
|
|
Trusting PharmaLast week’s post, “Curing Pharma,” struck a chord. Not only with the public relations and marketing execs who are RS Snapshot’s primary readers, but with researchers, investors, sales professionals and corporate strategists who shared their thoughts here, and on LinkedIn, on what it will take to rebuild public goodwill towards the pharmaceutical — and biotech — industries. Because those of you working in pharma and biotech are, understandably, sensitive to what may look like a ‘negativity rehash;” I want to say for the record that my intent is positive: to examine this topic in a public forum so that those of us who care (and know about RS Snapshot, so they can participate – please forward this to the best minds you know!) can find ways to constructively change the situation. Knee-jerk mistrust of the healthcare industry helps no one, patients least of all. I’m not the only one who feels a sense of urgency about this. Building trust doesn’t happen overnight and there is no time to waste. Please let me know: What topics you would like to see covered in this series? Leave a Reply |
|
| RSHC copyright © 2009 | |
Subscribe to our feed 
Subscribe to our 
Follow Snapshot on 
Join our network on 
Friend us on 